{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T08:30:14Z","timestamp":1789979414373,"version":"4.0.1"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1097\/jcp.0b013e31815ac4d2","type":"journal-article","created":{"date-parts":[[2009,3,4]],"date-time":"2009-03-04T20:27:58Z","timestamp":1236198478000},"page":"607-613","source":"Crossref","is-referenced-by-count":108,"title":["Delivery Outcome in Relation to Maternal Use of Some Recently Introduced Antidepressants"],"prefix":"10.1097","volume":"27","author":[{"given":"Roland","family":"Lennest\u00e5l","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bengt","family":"K\u00e4ll\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"9","key":"R1-9-20210128","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1017\/S1092852900019726","article-title":"SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants.","volume":"10","author":"Stahl","year":"2005","journal-title":"CNS Spectr"},{"issue":"2","key":"R2-9-20210128","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/hup.750","article-title":"A systematic review of the serotonergic effects of mirtazapine in humans: implications for its dual action status.","volume":"21","author":"Gillman","year":"2006","journal-title":"Hum Psychopharmacol"},{"issue":"9","key":"R3-9-20210128","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1358\/dot.1999.35.9.553218","article-title":"Reboxetine: a review of efficacy and tolerability.","volume":"35","author":"Delgado","year":"1999","journal-title":"Drugs Today (Barc)"},{"issue":"10","key":"R4-9-20210128","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1176\/appi.ajp.158.10.1728","article-title":"Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study.","volume":"158","author":"Einarson","year":"2001","journal-title":"Am J Psychiatry"},{"issue":"2","key":"R5-9-20210128","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.reprotox.2004.07.004","article-title":"Newer antidepressants in pregnancy: prospective outcome of a case series.","volume":"19","author":"Yaris","year":"2004","journal-title":"Reprod Toxicol"},{"issue":"8","key":"R6-9-20210128","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.4088\/JCP.v67n0817","article-title":"Exposure to mirtazapine during pregnancy: a prospective, comparative study of birth outcomes.","volume":"67","author":"Djulus","year":"2006","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"R7-9-20210128","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/0269881103017001716","article-title":"The pharmacovigilance of mirtazapine: results of a prescription event monitoring study on 13554 patients in England.","volume":"17","author":"Biswas","year":"2003","journal-title":"J Psychopharmacol"},{"issue":"2","key":"R8-9-20210128","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2165\/00002018-200528020-00005","article-title":"The safety of newer antidepressants in pregnancy and breastfeeding.","volume":"28","author":"Gentile","year":"2005","journal-title":"Drug Saf"},{"issue":"4","key":"R10-9-20210128","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/bdra.20327","article-title":"Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations.","volume":"79","author":"Kallen","year":"2007","journal-title":"Birth Defects Res"},{"issue":"11","key":"R12-9-20210128","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1503\/cmaj.051421","article-title":"Paroxetine (Paxil) and congenital malformations.","volume":"173","author":"Williams","year":"2005","journal-title":"CMAJ"},{"issue":"7","key":"R13-9-20210128","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2165\/00023210-200519070-00004","article-title":"SSRIs in pregnancy and lactation: emphasis on neurodevelopmental outcome.","volume":"19","author":"Gentile","year":"2005","journal-title":"CNS Drugs"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004714-200712000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:39:53Z","timestamp":1786037993000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004714-200712000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":11,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e31815ac4d2","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}